Neurology® Podcast
SPECIAL REPORT on Aducanumab Approval: Steve Pearson of ICER Discusses the Economic and Clinical Impact
- Author: Vários
- Narrator: Vários
- Publisher: Podcast
- Duration: 0:30:37
- More information
Informações:
Synopsis
Dr. Jason Crowell speaks with Dr. Steve Pearson, President of the Institute for Clinical and Economic Review, about the clinical and economic impact of aducanumab, a drug recently approved by the FDA for the treatment of Alzheimer disease.
